Apyx Medical Corporation (APYX) vs Unicycive Therapeutics, Inc. (UNCY)

A side-by-side comparison of Apyx Medical Corporation and Unicycive Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — APYX vs UNCY

growth of $100 · dividends reinvested · last 5y
APYX -73.0% (-23.0%/yr)UNCY -91.6% (-39.1%/yr)APYX compounded faster over this window
050100150Start $10020222023202420252026$27$8
APYX UNCY

APYX vs UNCY: by the numbers

  • •UNCY is the larger company ($113M vs $107M market cap).
  • •Both run net losses; UNCY's is the smaller (0.00% vs -14.78% net margin).

Metrics side by side

Valuation

MetricAPYXUNCY
P/S ratio1.83N/A
P/B ratio10.052.12

Profitability

MetricAPYXUNCY
Gross margin33.94%0.00%
Operating margin-6.06%0.00%
Net margin-14.78%0.00%
ROE-80.97%-66.12%
ROIC-6.84%-62.15%

Growth (annualized)

MetricAPYXUNCY
Revenue CAGR (5Y)8.82%N/A
Total return CAGR (5Y)-28.10%-32.14%

Frequently asked

How have APYX and UNCY total returns compared?
Over the past 5 years, APYX delivered -28.10% and UNCY delivered -32.14% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.